Abstract:A new infective outbreak, sustained by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and defined coronavirus disease 2019 (COVID-19), is now spreading all around the world.[1] The clinical course of this respiratory disease is complicated in up to 15% of infected patients by onset of interstitial pneumonia, evolving toward acute respiratory distress syndrome needing mechanical ventilation or admission to the intensive care unit (ICU), and is also often accompanied by multiorgan failure.[2] Since there is now incontrovertible evidence that laboratory hemostasis provides an essential contribution to decision-making and care of the vast majority of human pathologies,[3] we aimed to explore here whether increased D-dimer values—which are a frequent occurrence in patients with COVID-19[4]—may be associated with disease severity.An electronic search was performed in Medline (PubMed interface), Scopus, and Web of Science, using the keywords "laboratory" and "COVID-19" or "coronavirus 2019" or "2019-nCoV" or "SARS-CoV-2," between 2019 and present time (i.e., March 4, 2020), with no language restriction. The title, abstract, and full text of all documents that could be identified based on these search criteria were analyzed, and those reporting information on the difference of D-dimer values between COVID-19 patients with or without severe disease (i.e., those needing mechanical ventilation, ICU admission, or those who died) were finally included in our analysis. The reference list of each identified document was also examined for identifying additional eligible studies. A pooled analysis was finally performed, with calculation of weighted mean difference (WMD) and 95% confidence interval (CI) of D-dimer values between COVID-19 patients with or without severe disease, using MetaXL software Version 5.3 (EpiGear International Pty Ltd., Sunrise Beach, Australia). Mean and standard deviation were extrapolated from sample size, median, and interquartile range (IQR), according to Hozo et al.[5] The study was performed in accordance with the Declaration of Helsinki and with the term of local legislation.Overall, 80 documents could be initially identified based on our search criteria, 77 of which ought to be excluded after title, abstract, or full text reading; since they were review articles (n = 6), commentaries, or other editorial material (n = 1), they did not deal with COVID-19 disease (n = 62), or did not expressly reported the difference of D-dimer values in COVID-19 patients with or without severe disease (n = 8). One additional study could be identified from the reference list of selected articles and another one was published while the article was under revision so that a total number of five studies could finally be included in our analysis.[6] [7] [8] [9] [10] Four of these five studies reported median and IQR values of D-dimer,[6] [7] [8] [9] while the remaining only showed the proportion of patients with D-dimer values above the locally defined diagnostic cut-off.[9] In the first study, Huang et al reported clinical and laboratory data of 41 patients hospitalized with laboratory-confirmed COVID-19[6] and observed that D-dimer values were nearly fivefold higher in those with severe disease (median: 2.4 mg/L; IQR: 0.6–14.4 mg/L) than in those without (median: 0.5 mg/L; IQR: 0.3–0.8 mg/L; p = 0.004). Tang et al also studied 183 patients with COVID-19[7] and found that D-dimer values were nearly 3.5-fold higher in those with severe disease (median: 2.12 mg/L; IQR: 0.77–5.27 mg/L) than in those without (median: 0.61 mg/L; IQR: 0.35–1.29 mg/L; p < 0.001). In the third study, published by Wang et al and including 138 patients hospitalized for COVID-19,[8] D-dimer values were nearly 2.5-fold higher in patients with severe disease (median: 4.14 mg/L; IQR: 1.91–13.2 mg/L) than in those without (median: 1.66 mg/L; IQR: 1.01–2.85 mg/L; p < 0.001). In the third study, Zhou et al studied 191 patients with COVID-19[9] and found that D-dimer values were nearly ninefold higher in patients who died (median: 5.2 mg/L; IQR: 1.5–21.1 mg/L) than in those who survived (median: 0.6 mg/L; IQR: 0.3–1.0 mg/L; p < 0.001). In the study -Abstract Truncated-

Correlation of D-dimer and Outcomes in COVID-19 Patients

Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19

D-Dimer as a Predictor of Disease Outcome in Intensive Care SARS-COV-2 Patients: A Retrospective Study

Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019

A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19

D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19

Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression

D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis

D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis

Clinical Significance of Plasma D-Dimer in COVID-19 Mortality

D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19

The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients

D-dimer as an indicator of prognosis in SARS-CoV-2 infection: a systematic review

Prognostic capacity of D-dimer in predicting mortality in patients diagnosed with COVID-19

D-dimer level is a useful predictor for mortality in patients with COVID-19: Analysis of 483 cases

Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study

Evaluation of d-dimer as outcome biomarker in COVID-19 acute respiratory distress patients

Venous Thromboembolism and D-dimer In Patients with COVID-19

Does follow-up D-dimer level help in predicting oxygenation status, ventilatory support requirement, lung fibrosis, and thromboembolic events in coronavirus disease 2019 pneumonia? A prospective observational study in a tertiary care setting in India

Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis